• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Type 1 Interferon signalling in human intestinal T cells. 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Type 1 Interferon signalling in human intestinal T cells.
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Type 1 Interferon signalling in human intestinal T cells.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Type 1 Interferon signalling in human intestinal T cells.

    View/Open
    Giles_Edward_PhD_Final_181215.pdf (4.198Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    Intestinal immune homeostasis depends on the appropriate balance of pro-inflammatory and regulatory T cell activities which are themselves influenced by local mucosal signals. Dysregulation of these pathways leads to inflammatory bowel disease (IBD). Type 1 Interferon (T1IFN; IFNα/β), signalling via the phosphorylation of Signal Transduction and Activation of Transcription (STAT)1, is critical for innate protection against viruses but also has diverse effects on the immune system. They are potential local regulators of intestinal T cells. In mice, endogenous T1IFN ameliorates colitis by promoting regulatory T cell function. T1IFN has been used to treat IBD patients with limited success, but little is known about T1IFN in the human intestine. The aim of this work was test the hypothesis that T cells in the human intestine are modulated by intestinal factors such as T1IFN and that these responses are altered in IBD. A ‘Phosflow’ technique was developed to measure activation of key signalling molecules such as STATs at the single cell level. Responsiveness of human intestinal T cells to T1IFN was confirmed and increased expression of phosphorylated (p) STAT1 observed in CD4 T cells from IBD colonic tissue, irrespective of T1IFN stimulation. Increased pSTAT1 was associated with reduced expression of the STAT1 regulator SOCS1. Phosphorylation of STAT3 and STAT5 was not altered in IBD. Constitutive STAT1 phosphorylation was due in part to exposure to IFNβ. A potential role for T1IFN was supported by increased expression of Interferon Stimulated Genes (ISGs) by intestinal CD4 T cells in IBD and by the detection of endogenous IFNβ in fresh frozen sections of human colon. Addition of neutralising anti-IFNβ antibody to intestinal biopsy cultures led to an enhanced pro-inflammatory T cell cytokine profile and, in cells from healthy tissue, fewer IL10+ T cells. These data suggest that in health the endogenous T1IFN-STAT1 pathway supports a regulatory cytokine profile in human CD4+ intestinal T cells. There is evidence for dysregulation of this pathway in IBD, but the functional significance of this is less clear.
    Authors
    Giles, Edward Mark
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/12828
    Collections
    • Theses [3822]
    Copyright statements
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.